10-Q – Page 160 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2012 (unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months Ended March 31, 2012 and 2011 (unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer May 15, 2012] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and result of operations of thempany at thetes and for the periods indicated. Bing Mei Chief Financial Officer May 15, 2012]

By info| 2016-02-05T03:13:40+00:00 May 15th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2012-05-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0312ex32i_tianyin.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0312ex32ii_tianyin.htm CERTIFICATION]

By info| 2016-03-27T19:30:12+00:00 May 15th, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 10-Q, 2012-05-15, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

CREG [CHINA RECYCLING ENERGY] 10-Q: (Original Filing)

[] [10.1 No.: Bank of XI’AN South City Loan (2012) No. 7 Loan Contract for Working Capital Borrower: Xi’an TCH Energy Technology Co., Ltd Address: 86# Gaoxin Road, Gaoxin district, Xi’an Legal Representative: Ku Guohua Phone: Lender: Bank of XI’AN Co., Ltd. South City Branch Address: 1# Nan Guan Zheng Road Legal Representative: Li Peilin Phone: 87818014 Catalog Provision I Type] [CONVERTIBLE PROMISSORY NOTE TRANSFER AGREEMENT This CONVERTIBLE PROMISSORY NOTE TRANSFER AGREEMENT (the “Agreement”) is entered into as of the 28th day of April, 2012, by and among, Great Essential Investment, Ltd., a company registered in the Virgin Islands (“Great Essential”), Carlyle Asia Growth Partners III, L.P., a limited partnership organized under the laws of the Cayman Islands (“CAGP”) and CAGP] [CERTIFICATIONS I, Guohua Ku, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, David Chong, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. May 15, 2012 Guohua Ku Chairman of the Board and Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. May 15, 2012 David Chong Chief Financial Officer and Secretary]

By info| 2016-03-21T13:45:06+00:00 May 15th, 2012|Categories: Chinese Stocks, CREG, SEC Original|Tags: 0000721693, 10-Q, 2012-05-15, 7389, CREG, SERVICES-BUSINESS SERVICES, NEC|0 Comments

SORL [SORL Auto Parts] 10-Q: (Original Filing)

[] [Certification of Chief Executive Officer of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Certification of Principal Accounting Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: May 15, 2012 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer (Principal Accounting Officer)]

By info| 2016-03-26T21:56:40+00:00 May 15th, 2012|Categories: Chinese Stocks, SEC Original, SORL|Tags: 0000714284, 10-Q, 2012-05-15, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

CHLN [China Housing & Land Development] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, Xiaohong Feng, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Housing & Land Development, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATIONS I, Cangsang Huang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Housing & Land Development, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Xiaohong Feng Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2012 Cangsang Huang Chief Financial Officer (Principal Financial and Accounting Officer)]

By info| 2016-03-29T10:57:12+00:00 May 15th, 2012|Categories: Chinese Stocks, CHLN, SEC Original|Tags: 0001303330, 10-Q, 1520, 2012-05-15, CHLN, GEN BUILDING CONTRACTORS - RESIDENTIAL BUILDINGS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2012 President and Chief Executive Officer EX-32.1 4 cphi10qex321033112.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2012 (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qex322033112.htm]

By info| 2016-03-03T17:44:40+00:00 May 14th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2012-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x March 31, 2012

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2012 President and Chief Executive Officer EX-32.1 4 cphi10qex321033112.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2012 (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qex322033112.htm]

By info| 2016-03-03T17:46:11+00:00 May 14th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2012-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2012 President and Chief Executive Officer cphi10qex321033112.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2012 (principal financial officer and principal accounting officer) cphi10qex322033112.htm 5 EX-32.2]

By info| 2016-02-07T22:00:35+00:00 May 14th, 2012|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2012-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x March 31, 2012

[FORM 10-Q (Mark One) x March 31, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2012 President and Chief Executive Officer cphi10qex321033112.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 14, 2012 (principal financial officer and principal accounting officer) cphi10qex322033112.htm 5 EX-32.2]

By info| 2016-02-07T22:01:08+00:00 May 14th, 2012|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2012-05-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

SPU [SkyPeople Fruit Juice] 10-Q: (Original Filing)

[FORM 10-Q ý For the quarterly period ended March 31, 2012 ¨ For the transition period from ____ to ____ SKYPEOPLE FRUIT JUICE, INC. Florida 98-0222013 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 16F, China Development Bank Tower, No. 2, Gaoxin 1st Road, Xi’an, PRC 710075 86-29-88377161 N/A (Former name, former address and former fiscal] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yongke Xue, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of SkyPeople Fruit Juice, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Xin Ma, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of SkyPeople Fruit Juice, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein. Yongke Xue] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period presented therein. Xin Ma Principal Financial Officer and Principal Accounting Officer]

By info| 2016-04-01T14:56:50+00:00 May 14th, 2012|Categories: Chinese Stocks, SEC Original, SPU|Tags: 0001066923, 10-Q, 2012-05-14, 2030, CANNED, FROZEN and PRESERVED FRUIT, VEG and FOOD SPECIALTIES, SPU|0 Comments